1-3 of 3
Ryan D. Morin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The FBXO45–GEF-H1 Axis Controls Germinal Center Formation and B-cell Lymphomagenesis

Anagh A. Sahasrabuddhe, Xiaofei Chen, Kaiyu Ma, Rui Wu, Huan-Chang Liang, Richa Kapoor, Rishi R. Chhipa, Ozlem Onder, Courtney McFetridge, John S. Van Arnam, Xiao Zhang, Jennifer J.D. Morrissette, Vinodh Pillai, Marilyn M. Li, Philippe Szankasi, Venkatesha Basrur, Kevin P. Conlon, Tobias D. Raabe, Nathanael G. Bailey, Cory M. Hogaboam, Robert Rottapel, Junhyong Kim, Cristina López, Matthias Schlesner, Reiner Siebert, Kostiantyn Dreval, Ryan D. Morin, Loredana Moro, Michele Pagano, Louis M. Staudt, Megan S. Lim, Kojo S.J. Elenitoba-Johnson
Journal: Cancer Discovery
Cancer Discov (2025) 15 (4): 838–861.
https://doi.org/10.1158/2159-8290.CD-24-0442
Published: 02 April 2025
View articletitled, The FBXO45–GEF-H1 Axis Controls Germinal Center Formation and B-cell Lymphomagenesis
Open the PDF for The FBXO45–GEF-H1 Axis Controls Germinal Center Formation and B-cell Lymphomagenesis in another window
Includes: Supplementary data
Journal Articles

BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL

Min Xia, Liron David, Matt Teater, Johana Gutierrez, Xiang Wang, Cem Meydan, Andrew Lytle, Graham W. Slack, David W. Scott, Ryan D. Morin, Ozlem Onder, Kojo S.J. Elenitoba-Johnson, Nahuel Zamponi, Leandro Cerchietti, Tianbao Lu, Ulrike Philippar, Lorena Fontan, Hao Wu, Ari M. Melnick
Journal: Cancer Discovery
Cancer Discov (2022) 12 (8): 1922–1941.
https://doi.org/10.1158/2159-8290.CD-21-1566
Published: 05 August 2022
View articletitled, BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL
Open the PDF for BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL in another window
Includes: Multimedia, Supplementary data
Journal Articles

Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition

Daisuke Ennishi, Katsuyoshi Takata, Wendy Béguelin, Gerben Duns, Anja Mottok, Pedro Farinha, Ali Bashashati, Saeed Saberi, Merrill Boyle, Barbara Meissner, Susana Ben-Neriah, Bruce W. Woolcock, Adèle Telenius, Daniel Lai, Matt Teater, Robert Kridel, Kerry J. Savage, Laurie H. Sehn, Ryan D. Morin, Marco A. Marra, Sohrab P. Shah, Joseph M. Connors, Randy D. Gascoyne, David W. Scott, Ari M. Melnick, Christian Steidl
Journal: Cancer Discovery
Cancer Discov (2019) 9 (4): 546–563.
https://doi.org/10.1158/2159-8290.CD-18-1090
Published: 01 April 2019
View articletitled, Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition
Open the PDF for Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition in another window
Includes: Supplementary data